CTRN vs GILD · rev $753.1M vs P/E 18, rev $29.44B
Citi Trends Inc (CTRN) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Citi Trends Inc (CTRN) is a apparel retail company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported CTRN revenue for 2025-02-01 was $753.1M. Net income was -$43.2M. Revenue was up 0.7% from 2024-02-03 to 2025-02-01. CTRN currently screens at market cap $258.4M.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
CTRN currently screens at market cap $258.4M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the CTRN and GILD stock pages for the full models.
Not investment advice.